Evidence map›Paper›PMID 32377776›Full record

ArticleArchives of toxicology2020

MTH1 is involved in the toxic and carcinogenic long-term effects induced by zinc oxide and cobalt nanoparticles.

Irene Barguilla, Gabriela Barszczewska, Balasubramanyam Annangi, Josefa Domenech, Antonia Velázquez, Ricard Marcos, Alba Hernández

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of toxicology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Irene BarguillaGrup de Mutagènesi, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Edifici C, Campus de Bellaterra, 08193, Cerdanyola del Vallès (Barcelona), Spain.
Gabriela BarszczewskaGrup de Mutagènesi, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Edifici C, Campus de Bellaterra, 08193, Cerdanyola del Vallès (Barcelona), Spain.
Balasubramanyam AnnangiGrup de Mutagènesi, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Edifici C, Campus de Bellaterra, 08193, Cerdanyola del Vallès (Barcelona), Spain.
Josefa DomenechGrup de Mutagènesi, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Edifici C, Campus de Bellaterra, 08193, Cerdanyola del Vallès (Barcelona), Spain.
Antonia VelázquezGrup de Mutagènesi, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Edifici C, Campus de Bellaterra, 08193, Cerdanyola del Vallès (Barcelona), Spain.
Ricard MarcosGrup de Mutagènesi, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Edifici C, Campus de Bellaterra, 08193, Cerdanyola del Vallès (Barcelona), Spain. ricard.marcos@uab.es.
Alba HernándezGrup de Mutagènesi, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Edifici C, Campus de Bellaterra, 08193, Cerdanyola del Vallès (Barcelona), Spain. alba.hernandez@uab.cat.
Universitat Autònoma de Barcelona · ESCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESInstituto de Salud Carlos III · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The nanoparticles (NPs) exposure-related oxidative stress is considered among the main causes of the toxic effects induced by these materials. However, the importance of this mechanism has been mostly explored at short term. Previous experience with cells chronically exposed to ZnO and Co NPs hinted to the existence of an adaptative mechanism contributing to the development of oncogenic features. MTH1 is a well-described enzyme expressed exclusively in cancer cells and required to avoid the detrimental consequences of its high prooxidant microenvironment. In the present work, a significantly marked overexpression was found when MTH1 levels were monitored in long-term ZnO and Co NP-exposed cells, a fact that correlates with acquired 2.5-fold and 3.75-fold resistance to the ZnO and Co NPs treatment, respectively. The forced stable inhibition of Mth1 expression by shRNA, followed by 6 additional weeks of exposure, significantly reduced this acquired resistance and sensitized cells to the oxidizing agents H

Indexed as

AnimalsCell LineCell MovementCell ProliferationCell Transformation, NeoplasticCobaltDNA DamageDNA GlycosylasesFibroblastsMetal NanoparticlesMiceNeoplasm InvasivenessOxidative StressPhosphoric Monoester HydrolasesTime FactorsZinc OxideCobaltDNA GlycosylasesNudt1 protein, mouseOgg1 protein, mousePhosphoric Monoester HydrolasesZinc OxideCobalt nanoparticlesLong-term exposureMechanisms of carcinogenesisMTH1Oxidative damageZinc oxide nanoparticles

Identifiers

PMID32377776
OpenAlexW3023439396

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.